Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luminespib in ALK-Positive Advanced NSCLC
NCT01752400Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 2013
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Luminespib in non-small cell lung cancer (NSCLC), sponsored by Massachusetts General Hospital. Started Jan 2013; status: completed.
02
Drugs
Luminespib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01752400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01752400.